📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Definigen

1.1 - Company Overview

Definigen Logo

Definigen

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of in-vitro liver and metabolic disease models using iPSC technology to generate pre-clinical human data, offering Opti-HEPs for drug efficacy and predictive toxicology screening, phenotypic screening with bioassays, and custom disease model development via CRISPR. Includes models for Alpha-1 Antitrypsin Deficiency, Wilson's Disease (ATP7B), and Glycogen Storage Disease Type 1 Alpha.

Products and services

  • Phenotypic Screening Service: Assay-integrated service combining iPSC-derived hepatocyte models with bioassays to screen therapeutic candidates and generate pre-clinical human data in liver and metabolic disease contexts
  • Custom Model Development: Custom-engineered service architecting tailored disease models with CRISPR gene editing and iPSC technology to support drug discovery in liver and metabolic disease research
  • Opti-HEPs: Research-grade iPSC-derived hepatocyte-like cells engineered via the OptiDIFF platform for drug efficacy testing and predictive toxicology screening in in-vitro liver and metabolic disease models

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Definigen

Purolite Logo

Purolite

HQ: United Kingdom Website
  • Description: Provider of pharmaceutical resin products used as APIs or excipients; marketed APIs cholestyramine and sodium polystyrene sulfonate; excipients for taste-masking, carriers, and disintegrants; PuroMill pharmaceutical-grade milling media for nanoparticles <100 nm to enhance solubility; and polymeric and chromatography resins for biofluid treatment, separation, purification, and medical device diagnostic and treatment applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Purolite company profile →
Nanalysis Logo

Nanalysis

HQ: Canada Website
  • Description: Provider of portable benchtop nuclear magnetic resonance (NMR) spectrometers and supporting software for biotech, pharmaceutical, research, and education applications. Offerings include 100 MHz and 60 MHz NMR spectrometers, NMReady-CONNECT for remote control/monitoring, pulse sequence design, time-based kinetics experiments, and IQ/OQ modules for performance validation and regulatory compliance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nanalysis company profile →
Seraxis Logo

Seraxis

HQ: United States Website
  • Description: Provider of cell replacement therapy and lab-grown pancreatic islets for insulin-dependent diabetes. Offerings include SR-01, which combines lab-grown human islets with a technology to implant these islets without immune suppression; SR1423, a stem cell line maturing into insulin-secreting islets; and lab-grown islets that mimic native pancreatic function and respond to glucose.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Seraxis company profile →
PanThera CryoSolutions Logo

PanThera CryoSolutions

HQ: Canada Website
  • Description: Provider of cryopreservation solutions for cells, tissues, and organs, featuring IRIs that control ice crystal size and growth to improve cell recovery/quality and reduce warming damage; IRIs mitigate toxicity of conventional cryoprotective agents to enable higher sub-zero storage temperatures, with GMP-compliant manufacturing and less costly storage/transport, restricting liquid nitrogen use in some cell treatment applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PanThera CryoSolutions company profile →
Cellix Logo

Cellix

HQ: Ireland Website
  • Description: Provider of microfluidic pumping solutions, consumable biochips, software, and automated solutions for cell biology, microfluidics and nanofluidics, physics, chemistry, and cell and particle studies. Offerings include pulse-free syringe, pressure and recirculating pumps with PC control, VenaFlux for shear flow assays, the Inish Analyser for label-free cell counting, viability and transfection efficiencies, and disposable biochips for flow and droplet studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cellix company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Definigen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Definigen

2.2 - Growth funds investing in similar companies to Definigen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Definigen

4.2 - Public trading comparable groups for Definigen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Definigen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Definigen

What does Definigen do?

Definigen is a provider of in-vitro liver and metabolic disease models using iPSC technology to generate pre-clinical human data, offering Opti-HEPs for drug efficacy and predictive toxicology screening, phenotypic screening with bioassays, and custom disease model development via CRISPR. Includes models for Alpha-1 Antitrypsin Deficiency, Wilson's Disease (ATP7B), and Glycogen Storage Disease Type 1 Alpha.

Who are Definigen's competitors?

Definigen's competitors and similar companies include Purolite, Nanalysis, Seraxis, PanThera CryoSolutions, and Cellix.

Where is Definigen headquartered?

Definigen is headquartered in United Kingdom.

How many employees does Definigen have?

Definigen has 1,000 employees 🔒.

When was Definigen founded?

Definigen was founded in 2010 🔒.

What sector and industry vertical is Definigen in?

Definigen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Definigen

Who are the top strategic acquirers in Definigen's sector and industry

Top strategic M&A buyers and acquirers in Definigen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Definigen?

Top strategic M&A buyers groups and sectors for Definigen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Definigen's sector and industry vertical

Which are the top PE firms investing in Definigen's sector and industry vertical?

Top PE firms investing in Definigen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Definigen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Definigen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Definigen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Definigen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Definigen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Definigen?

The key public trading comparables and valuation benchmarks for Definigen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Definigen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Definigen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Definigen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Definigen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Definigen's' sector and industry vertical?

Access recent funding rounds and capital raises in Definigen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Definigen